found that TMAO promoted calcium/phosphate-induced calcification in the vascular smooth muscle cells of rats and human urinary system patients in a dose-dependent manner, and upregulated the expression of bone-related molecules (Runt-related transcription factor2, Runx2, and Bone morphogenetic protein-2, BMP2)
Hitting a weight loss plateau is frustrating
(Doctor of Pharmacy) Dr
17% placebo) Improvements in cardiometabolic risk factors Safety profile consistent with GLP-1RA class GI side effects were common but led to low discontinuation (4.5%) Conducted across Japan and South Korea Takeaway : Oral semaglutide may offer a potent weight management tool in East Asian patients, where obesity-related risk occurs at lower BMIs. Title : Oral Semaglutide in an East Asian Population With Overweight or Obesity, With or Without Type 2 Diabetes Authors : Takashi Kadowaki, Line Dam Heftdal, Hae-Jin Ko Read the Full Article on JAMA Internal Medicine More posts featuring Yan Leyfman .
They also observed significant reductions (7580%) in liver fat and knee pain (75.8%), as well as cholesterol and blood pressure
- Perhatikan komposisi lain seperti kolagen, vitamin C, dan pemanis
